Close



Apr 8, 2024 12:01PM
Apr 8, 2024 12:00PM
Mar 21, 2024 07:00AM
Mar 6, 2024 08:30AM
Mar 6, 2024 08:30AM
Feb 14, 2024 08:00AM
Feb 6, 2024 08:02AM MiNK Therapeutics' (INKT) AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress
Feb 6, 2024 08:00AM
Feb 6, 2024 08:00AM
Jan 30, 2024 08:00AM
Dec 20, 2023 07:31AM
Dec 20, 2023 07:30AM
Nov 9, 2023 07:00AM
Nov 3, 2023 12:02PM MiNK Therapeutics (INKT) Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors
Nov 3, 2023 12:00PM
Aug 10, 2023 07:30AM
May 22, 2023 08:30AM
May 18, 2023 08:30AM
May 18, 2023 08:30AM
Apr 18, 2023 01:33PM
Apr 18, 2023 01:32PM MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting
Apr 18, 2023 01:32PM
Nov 10, 2022 09:05AM
Mar 18, 2022 08:31AM
Mar 18, 2022 08:30AM
Mar 18, 2022 08:30AM
Mar 3, 2022 04:35PM
Mar 3, 2022 09:28AM MiNK Therapeutics Announces Patients Dosed with AgenT-797 iNKT Cell Therapy in Solid Tumor Cancers
Nov 9, 2021 08:00AM
Oct 12, 2021 06:14AM

51,661 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All